Abstract
Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.
| Original language | English |
|---|---|
| Pages (from-to) | 399-401 |
| Number of pages | 3 |
| Journal | Expert Opinion on Drug Safety |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - May 2005 |
Fingerprint
Keywords
- Contrast-enhanced ultrasound (CEUS)
- Hepatocellular carcinoma
- Intraoperative ultrasonography
- Liver cirrhosis
- Liver metastases
- Liver tumour
ASJC Scopus subject areas
- Pharmacology
Cite this
Adverse effects associated with SonoVue® use. / Torzilli, Guido.
In: Expert Opinion on Drug Safety, Vol. 4, No. 3, 05.2005, p. 399-401.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Adverse effects associated with SonoVue® use
AU - Torzilli, Guido
PY - 2005/5
Y1 - 2005/5
N2 - Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.
AB - Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL). Contrast-enhanced ultrasound (CEUS) significantly improves the diagnostic performance of US in the assessment of FLL. Rare reports of serious adverse events have been reported with CEUS. The rates of adverse reactions reported from the use of ultrasound contrast agents seem comparable to, or lower than, those observed for other imaging modalities that use contrast agents such as computed tomography and magnetic resonance imaging. Improved diagnostic results and diagnostic confidence achieved in conventional CEUS studies of the liver and during the investigational use in the intraoperative CEUS exploration appear to justify the use of this promising modality.
KW - Contrast-enhanced ultrasound (CEUS)
KW - Hepatocellular carcinoma
KW - Intraoperative ultrasonography
KW - Liver cirrhosis
KW - Liver metastases
KW - Liver tumour
UR - http://www.scopus.com/inward/record.url?scp=19444373922&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19444373922&partnerID=8YFLogxK
U2 - 10.1517/14740338.4.3.399
DO - 10.1517/14740338.4.3.399
M3 - Article
C2 - 15934848
AN - SCOPUS:19444373922
VL - 4
SP - 399
EP - 401
JO - Expert Opinion on Drug Safety
JF - Expert Opinion on Drug Safety
SN - 1474-0338
IS - 3
ER -